Viridian Therapeutics, Inc. (VRDN)

17.62 +0.17 (+0.97%) USD  |  NASDAQ  |  May 29, 16:00
17.82 +0.20 (+1.14%) After-Hours: 20:00
More

Viridian Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Spyre Therapeutics, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade
CAMP4 Therapeutics Corp. --
Savara, Inc. Upgrade